TAK - Takeda Pharmaceutical Co - ADR
Close
14.89
-0.060 -0.403%
Share volume: 1,859,532
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$14.95
-0.06
-0.40%
Summary score
43%
Profitability
17%
Dept financing
28%
Liquidity
54%
Performance
70%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.95%
Return on assets
0.95%
Return on sales
13.49%
Return on invested capital
0.65%
Total debt ratio
54.79%
Debt ratio change over timeo
30.13%
Current Ratio
1.18%
Quick Ratio
0.73%
Cash Position Ratio
0.29%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.48%
Return on assets
0.66%
Return on sales
8.81%
Return on invested capital
0.35%
Total debt ratio
52.22%
Debt ratio change over timeo
-96.89%
Current Ratio
1.12%
Quick Ratio
0.61%
Cash Position Ratio
0.2%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
1.22%
Return on assets
1.35%
Return on sales
18.13%
Return on invested capital
0.89%
Total debt ratio
51.94%
Debt ratio change over time
45.74%
Current Ratio
1.26%
Quick Ratio
0.74%
Cash Position Ratio
0.33%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-32.58%
Return on assets
-26.15%
Return on sales
1016.51%
Return on invested capital
-57.35%
Total debt ratio
3013.04%
Debt ratio change over time
30.13%
Current Ratio
75.31%
Quick Ratio
57.98%
Cash Position Ratio
30.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TAK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0.95% | 15.38% | 0% | 8.06% |
| Return on assets | 0.95% | 4.28% | 0% | 3.29% |
| Return on sales | 13.49% | 28.78% | 0% | 25.89% |
| Return on invested capital | 0.65% | 9.98% | 0% | 8.2% |
| Profitability | 20% | 100% | 0% | 75% |
| Total debt ratio | 54.79% | 81.15% | 0% | 59.44% |
| Debt ratio change over time | 30.13% | -8.61% | 0% | -44.03% |
| Dept financing | 42% | 25% | 0% | 18% |
| Current Ratio | 1.12% | 0% | 0% | 1.07% |
| Quick Ratio | 0.61% | 0% | 0% | 0.85% |
| Cash Position Ratio | 0.2% | 0% | 0% | 0.47% |
| Liquididy | 54% | 54% | 0% | 75% |
| Short-term ratios | TAK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0.48% | 0% | 0% | 6.55% |
| Return on assets | 0.66% | 0% | 0% | 3.57% |
| Return on sales | 8.81% | 0% | 0% | 28.77% |
| Return on invested capital | 0.35% | 0% | 0% | 6.76% |
| Profitability | 15% | 0% | 0% | 100% |
| Total debt ratio | 52.22% | 0% | 0% | 60.5% |
| Debt ratio change over time | -96.89% | 0% | 0% | 7.95% |
| Dept financing | 22% | 0% | 0% | 50% |
| Current Ratio | 1.12% | 0% | 0% | 1.07% |
| Quick Ratio | 0.61% | 0% | 0% | 0.85% |
| Cash Position Ratio | 0.2% | 0% | 0% | 0.47% |
| Liquididy | 54% | 0% | 0% | 74% |